MNKD Company Profile and Key Details

Q: Who are the executives of MNKD?

Ms. Rosabel Realica AlinayaVice President of Investor Relations & TreasuryMr. John F. BedardSenior Vice President of Worldwide Regulatory AffairsMr. James Patrick McCauley Jr., J.D., M.B.A.Chief Commercial OfficerDr. Stuart A. Tross Ph.D.Executive Vice President and Chief People & Workplace OfficerMr. Joseph Kocinsky M.B.A., M.S.Chief Technology OfficerDr. Michael E. Castagna Pharm.D.Chief Executive Officer & DirectorMr. Steven B. BinderChief Financial OfficerDr. David B. ThomsonExecutive Vice President, Gen. Counsel & Sec.Mr. Sanjay Singh M.B.A.Executive Vice President of Technical OperationsMs. Lauren M. SabellaExecutive Vice President & Chief Operating OfficerMr. Thomas Hofmann M.D., Ph.D.Senior Vice President & Chief Scientific Officer

NASDAQ : MNKD

MannKind

$3.93

0.09+2.34%

At Close 4:00 PM

57.88

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MannKind Corporation (MNKD) stock surged +2.34%, trading at $3.93 on NASDAQ, up from the previous close of $3.84. The stock opened at $3.86, fluctuating between $3.77 and $3.95 in the recent session.

Stock Snapshot

3.84

Prev. Close

1.21B

Market Cap

3.77

Day Low

-57.91

P/E Ratio

-0.06786

EPS (TTM)

-0.03

Cash Flow per Share

3.86

Open

308.95M

Number of Shares

3.95

Day High

98.11%

Free Float in %

-0.91

Book Value

3.23M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 25, 2026	3.85	3.95	3.77	3.93	3.23M
Jun 24, 2026	3.94	3.99	3.80	3.84	4.48M
Jun 23, 2026	3.86	3.94	3.85	3.93	2.99M
Jun 22, 2026	3.95	4.06	3.88	3.89	3.56M
Jun 18, 2026	4.00	4.02	3.83	3.94	16.62M
Jun 17, 2026	3.89	4.02	3.88	3.92	3.66M
Jun 16, 2026	4.00	4.04	3.84	3.87	3.16M
Jun 15, 2026	3.73	4.06	3.70	4.00	5.6M
Jun 12, 2026	3.75	3.81	3.64	3.66	3.84M
Jun 11, 2026	3.63	3.79	3.55	3.75	4.07M
Jun 10, 2026	3.50	3.74	3.48	3.63	4.38M
Jun 09, 2026	3.44	3.60	3.41	3.57	4.91M
Jun 08, 2026	3.45	3.52	3.38	3.39	2.34M
Jun 05, 2026	3.53	3.53	3.39	3.40	3.24M
Jun 04, 2026	3.35	3.53	3.34	3.52	3.51M
Jun 03, 2026	3.43	3.53	3.30	3.36	3.35M
Jun 01, 2026	3.76	3.81	3.41	3.53	8.33M
May 29, 2026	3.66	3.94	3.51	3.77	20.3M
May 28, 2026	3.57	3.68	3.47	3.64	5.43M
May 27, 2026	3.53	3.63	3.44	3.55	3.56M

Contact Details

Danbury, CA 91362

United States

https://www.mannkindcorp.com 818 661 5000

About Company

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.

Stock Peers

ARGX

36.15+4.24%

argenx SE$888.65 REGN

-3.29-0.53%

Regeneron Pharmaceuticals, Inc.$620.14 UTHR

-6.51-1.18%

United Therapeutics Corporation$543.39 MDGL

4.03+0.79%

Madrigal Pharmaceuticals, Inc.$513.79 VRTX

4.98+1.05%

Vertex Pharmaceuticals Incorporated$480.18 KRYS

12.3+3.54%

Krystal Biotech, Inc.$359.93 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

18.92+6.12%

Praxis Precision Medicines, Inc.$327.86 LGND

11.01+3.86%

Ligand Pharmaceuticals Incorporated$295.92 ALNY

-0.89-0.30%

Alnylam Pharmaceuticals, Inc.$293.17

Frequently Asked Questions

What is the current MannKind Corporation (MNKD) stock price?

MannKind Corporation (NASDAQ: MNKD) stock price is $3.93 in the last trading session. During the trading session, MNKD stock reached the peak price of $3.95 while $3.77 was the lowest point it dropped to. The percentage change in MNKD stock occurred in the recent session was 2.34% while the dollar amount for the price change in MNKD stock was $0.09.

MNKD's industry and sector of operation?

The NASDAQ listed MNKD is part of Biotechnology industry that operates in the broader Healthcare sector. MannKind Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNKD?

Ms. Rosabel Realica Alinaya
Vice President of Investor Relations & Treasury
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
Dr. Stuart A. Tross Ph.D.
Executive Vice President and Chief People & Workplace Officer
Mr. Joseph Kocinsky M.B.A., M.S.
Chief Technology Officer
Dr. Michael E. Castagna Pharm.D.
Chief Executive Officer & Director
Mr. Steven B. Binder
Chief Financial Officer
Dr. David B. Thomson
Executive Vice President, Gen. Counsel & Sec.
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Lauren M. Sabella
Executive Vice President & Chief Operating Officer
Mr. Thomas Hofmann M.D., Ph.D.
Senior Vice President & Chief Scientific Officer

How MNKD did perform over past 52-week?

MNKD's closing price is 76.23% higher than its 52-week low of $2.23 where as its distance from 52-week high of $6.51 is -39.63%.

How many employees does MNKD have?

Number of MNKD employees currently stands at 403.

Link for MNKD official website?

Official Website of MNKD is: https://www.mannkindcorp.com

How do I contact MNKD?

MNKD could be contacted at phone 818 661 5000 and can also be accessed through its website. MNKD operates from 30930 Russell Ranch Road, Danbury, CA 91362, United States.

How many shares of MNKD are traded daily?

MNKD stock volume for the day was 3.23M shares. The average number of MNKD shares traded daily for last 3 months was 5.43M.

What is the market cap of MNKD currently?

The market value of MNKD currently stands at $1.21B with its latest stock price at $3.93 and 308.95M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	403
Beta	1.11
Sales or Revenue	$198.96M
5Y Sales Change%	2.855%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	403
Beta	1.11
Sales or Revenue	$198.96M
5Y Sales Change%	2.855%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MNKD Company Profile and Key Details

MannKind

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways